49
Participants
Start Date
April 3, 2020
Primary Completion Date
June 1, 2020
Study Completion Date
June 1, 2020
Convalescent plasma
400 ml of convalescent plasma (plasma taken 2 weeks from the recovered COVID-19 patients) and was transfused over 1-2 hours to the recipients by blood donation set.
Hydroxychloroquin with Azithromycin
The control group of COVID-19 patients were given the conventional therapy approved in Iraq for COVID-19, namely Hydroxychloroquine 400mg PO twice per day for 5 days and Azithromycin once PO 500 mg per day for 5 days.
Akarkh Healt hdirectorate, Baghdad
Alkarkh Health Directorate-Baghdad
OTHER_GOV